Fengwang Mao

**Title: The Innovative Contributions of Fengwang Mao**

Introduction

Fengwang Mao is a notable inventor based in Shanghai, China, recognized for his contributions to pharmaceutical innovations. With one patent to his name, Mao has made significant strides in the development of new chemical compounds that have the potential to enhance medical therapies.

Latest Patents

Mao's recent patent is titled "Acetatic Abiraterone Trifluoroacetate and Preparation Method and Application of Same." This innovative compound is obtained through a salt-forming reaction between acetaic abiraterone and trifluoroacetic acid. The meticulous preparation method results in acetaic abiraterone trifluoroacetate, which undergoes self-purification through recrystallization. This process ensures that the final product exhibits high purity, high yield, and stable quality, making it suitable for mass production.

Career Highlights

Throughout his career, Fengwang Mao has collaborated with leading pharmaceutical companies, specifically Shanghai Cdymax Pharmaceuticals Co., Ltd. and Jiangsu Cdymax Pharmaceuticals Co., Ltd. His work has focused on the advancement of medicinal chemistry and the creation of compounds with therapeutic potential.

Collaborations

Mao has worked alongside talented professionals such as Xiaoxia An and Chengjun Huang. These collaborations have facilitated the exchange of ideas and enhanced the research efforts that contribute to the pharmaceutical industry.

Conclusion

Fengwang Mao exemplifies the innovative spirit of inventors in the field of pharmaceuticals. His work on acetaic abiraterone trifluoroacetate showcases not only his expertise but also his commitment to advancing medical science through inventive research and development. As the landscape of pharmaceuticals continues to evolve, inventors like Mao will play a crucial role in shaping the future of healthcare solutions.